CS&D Technical Lead Architect - CTI MD Tech (LRL)

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.  LRL takes potential marketable products from Research through product registration and approval, enabling MDU's business needs of the future through information and technology solutions. Within this portfolio, Clinical Supply & Delivery (CS&D) owns the systems and platforms that move investigational drug product — from packaging and labeling through distribution and fulfillment — to clinical trial sites, reliably, compliantly, and on time for trial execution. The CS&D Technical Lead Architect owns end-to-end technical architecture for these platforms — moving CS&D from point-solution delivery to a coherent, agentic-AI-enabled architecture, and from reactive engineering support to proactive, roadmapped portfolio transformation. Path/Level: R5 (CS&D Technical Lead Architect) This role is split roughly 70% hands-on technical execution — building agentic architecture, integration patterns, and platform capability directly — and 30% strategy, roadmap ownership, and portfolio-level transformation planning. The CS&D Technical Lead Architect shapes the future technology landscape for CS&D's clinical supply and trial-material delivery platforms, aligning business strategy with technology investment, AI/agentic innovation, and architecture to drive operational excellence, compliance, and scalable transformation.

Portfolio Architecture Ownership (Hands-On) — design, build, and directly implement the technical architecture for CS&D's critical platforms — containerized services, CI/CD pipelines, cloud infrastructure, data pipelines, and integration layers; own architecture roadmaps and standards for the platforms in scope, preparing decisions ahead of delivery rather than resolving them reactively. (placeholder — confirm scope: demand/supply forecasting, packaging & labeling, distribution and site-level fulfillment, trial-material tracking) Agentic AI & Portfolio Transformation — drive a portfolio-wide exploration of AI/agentic opportunities across CS&D's platforms; evaluate build-vs-buy for each opportunity; own and evolve a staged, roadmapped vision for shifting CS&D's architecture toward agentic-based patterns wherever viable, sequencing the transformation gradually rather than as a single cutover; convert validated proofs-of-concept into production-grade, reusable agentic architecture. Governance, Risk & GxP/GCP Compliance — embed audit-readiness, security and change-control thinking into architecture patterns; ensure designs meet FDA/EMA and internal IT/quality policy requirements, including GMP, GCP considerations relevant to clinical trial material handling; maintain architecture documentation supporting audit, inspection, and CSV readiness across the platforms owned. Technology Evaluation & Platform Modernization — evaluate emerging cloud, data, and AI/agentic technologies for CS&D applicability; run staged proofs-of-concept before adoption; identify and retire technical debt, consolidating and simplifying the platform footprint. Business & Product Partnership — partner with product managers and business stakeholders to translate business goals, capabilities, and value-streams into technical solutions; lead architectural discussions and decision-making, facilitate knowledge-sharing, and manage expectations through clear communication.